New national guidelines for anal cancer prevention in HIV patients based on UCSF research.
Results from a national study led by UC San Francisco informed the first guidelines at the federal level in the United States to detect and treat anal cancer precursor lesions in people with HIV to reduce the risk of developing anal cancer.
The guidelines were published on July 9 by a panel of experts in HIV care, utilizing findings from the Anal Cancer/HSIL Outcomes Research (ANCHOR) trial led by Joel M. Palefsky, MD, a professor of medicine in the UCSF Infectious Disease Division. The ANCHOR study was funded by the National Cancer Institute (NCI) of the National Institutes of Health NIH and conducted by the AIDS Malignancy Consortium.
Read More by clicking here: https://www.news-medical.net/news/20240719/New-national-guidelines-for-anal-cancer-prevention-in-HIV-patients-based-on-UCSF-research.aspx
